Long QT Syndrome Clinical Trials Long QT Syndrome RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine
Condition:   Long QT Syndrome Type 3Intervention:   Drug: RanolazineSponsor:   Tel-Aviv Sourasky Medical CenterRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 12, 2012 Category: Research Source Type: clinical trials